loading

Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
90.74%
2.7805
1.4578 3.1291 2.9946 2.9393
Depreciation and Amortization
30.10%
0.0153
0.0219 - - -
Operating Income/Loss
90.74%
-2.7805
-1.4578 -3.1291 -2.9946 -2.9393
Income/Loss From Continuing Operations Before Tax
90.18%
-2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
90.18%
-2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Net Income/Loss
290.18%
2.7757
-1.4595 -3.1008 -2.5571 -2.9427
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
5.5514
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$295.27
price up icon 2.64%
$138.05
price down icon 1.35%
diagnostics_research DGX
$173.09
price down icon 2.63%
diagnostics_research LH
$252.80
price up icon 0.36%
diagnostics_research MTD
$1,259.39
price up icon 3.30%
diagnostics_research IQV
$191.76
price up icon 2.42%
Kapitalisierung:     |  Volumen (24h):